Back to top
more

Chemed (CHE)

(Real Time Quote from BATS)

$588.69 USD

588.69
49,033

+10.92 (1.89%)

Updated Oct 8, 2024 03:54 PM ET

After-Market: $587.22 -1.47 (-0.25%) 4:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 10% (25 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Align Technology Rides High on InvisAlign & Strategic Pacts

Rising demand for InvisAlign products in the global teen market and the distribution agreement with Patterson Dental are major upsides for Align (ALGN).

    Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources

    Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources

      Tirthankar Chakraborty headshot

      5 of the Most Efficient Stocks to Boost Your Portfolio

      Company with a favorable efficiency level generally provides impressive returns as it is believed to be positively correlated with the stock's price performance.

        Envision Healthcare Down More Than 50% This Year, Here's Why

        Envision Healthcare (EVHC) seems to be bogged down by soft patient volumes, increasing expenses and high leverage.

          Chemed (CHE) Up 13.6% Since Earnings Report: Can It Continue?

          Chemed (CHE) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

            Envision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised)

            Envision Healthcare (EVHC) stock suffers on soft third-quarter results and a tepid outlook.

              Envision Healthcare Hits 52-Week Low on Q3 Loss, Grim View

              Envision Healthcare (EVHC) stock suffers on soft third-quarter results and a tepid outlook.

                Envision Healthcare Continues to Expand Physician Services

                Envision Healthcare's (EVHC) numerous acquisitions and management changes are aimed at growing its physician services segment.

                  STERIS (STE) Rides on Organic Growth, Stiff Contest a Threat

                  STERIS' (STE) consistent strong organic all-segment growth performance impresses investors. Additionally, growth in free cash flow reserve denotes the company's solid cash position.

                    AmerisourceBergen's PharMEDium Slows Down, Competition Rife

                    AmerisourceBergen Corporation's (ABC) expects tepid performance from PharMEDium due to pricing pressure in the generic drug space.

                      CVS Health Gains on Pharmacy Services, Retail Remains a Drag

                      CVS Health (CVS) benefits from strong Pharmacy Services numbers and continues to deliver solid PBM selling seasons. Retail performance stays sluggish on several headwinds.

                        Brian Bolan headshot

                        Omnova Solutions and Chemed are Zacks Aggressive Growth Rank Buys

                        OMN and CHE are profiled as aggressive growth stocks.

                          Why Is Chemed (CHE) Down 7.8% Since the Last Earnings Report?

                          Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                            Here's Why You Must Add Chemed (CHE) Stock to Your Portfolio

                            Chemed Corporation's (CHE) promising Roto-Rooter revenue outlook as well as an increased bottom-line guidance bode well of the company's future.

                              Zacks.com featured highlights: Arkema SA, Nutrisystem, Braskem SA, Chemed and SP Plus

                              Zacks.com featured highlights: Arkema SA, Nutrisystem, Braskem SA, Chemed and SP Plus

                                5 Top Stocks With Solid Net Profit Margin

                                Net profit is the amount a company retains after deducting all costs, interest, depreciation, taxes and other expenses.

                                  Envision Healthcare Hurt by High Debt, Increasing Expenses

                                  Envision Healthcare's (EVHC) increasing debt and expenses continue to hurt. Further guidance cut by the company is concerning.

                                    Zacks.com featured highlights: Arkema, Nutrisystem, SYNNEX, Ituran Location and Control and Chemed

                                    Zacks.com featured highlights: Arkema, Nutrisystem, SYNNEX, Ituran Location and Control and Chemed

                                      5 Top Stocks with Stellar Net Profit Margin

                                      Net profit is the amount a company retains after deducting all costs, interest, depreciation, taxes and other expenses.

                                        Chemed (CHE) Q2 Earnings & Revenues Rise Y/Y, View Revised

                                        Chemed (CHE) rides high on Roto-Rooter in second-quarter 2017. An encouraging bottom-line projection raises hopes.

                                          Chemed (CHE) Up 6.4% Since Earnings Report: Can It Continue?

                                          Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                            Amedisys (AMED) Catches Eye: Stock Gains 6.2% in Session

                                            Amedisys, Inc. (AMED) moved big last session, as its shares rose over 6% on the day.

                                              Chemed (CHE) Misses Q4 Earnings, Sales; Offers '17 View

                                              Chemed Corp.'s (CHE) fourth-quarter 2016 adjusted earnings per share (EPS) was $2.02, missing the Zacks Consensus Estimate by 4.3%.

                                                Chemed (CHE): Roto-Rooter Solid, Reimbursement a Concern

                                                On Dec 20, we issued an updated research report on Cincinnati, OH-based Chemed Corporation (CHE).

                                                  David Bartosiak headshot

                                                  5 Best Healthcare Bargain Stocks to Buy

                                                  Healthcare stocks have been beaten down by the market, you need to buy these STAT!